Harry Theodore Anastopoulos, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroenterology | 1 | 2016 | 593 | 0.080 |
Why?
|
| Colonoscopy | 1 | 2016 | 1409 | 0.070 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 2 | 1999 | 95 | 0.070 |
Why?
|
| Portasystemic Shunt, Surgical | 2 | 1996 | 40 | 0.070 |
Why?
|
| Sulfasalazine | 1 | 2003 | 85 | 0.050 |
Why?
|
| Lymphocytosis | 1 | 2003 | 121 | 0.050 |
Why?
|
| Liver Failure | 1 | 2003 | 252 | 0.050 |
Why?
|
| Hemorrhoids | 1 | 1999 | 19 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2003 | 599 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2016 | 4859 | 0.040 |
Why?
|
| Colostomy | 1 | 1999 | 107 | 0.040 |
Why?
|
| Ileostomy | 1 | 1999 | 122 | 0.040 |
Why?
|
| Varicose Veins | 1 | 1999 | 158 | 0.040 |
Why?
|
| Hepatic Encephalopathy | 2 | 1999 | 143 | 0.040 |
Why?
|
| Hydrothorax | 1 | 1997 | 20 | 0.040 |
Why?
|
| Hypertension, Portal | 1 | 1999 | 229 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2003 | 616 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 6966 | 0.030 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 1996 | 222 | 0.030 |
Why?
|
| Drug Hypersensitivity | 1 | 2003 | 903 | 0.030 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 1995 | 128 | 0.030 |
Why?
|
| Ascites | 1 | 1996 | 336 | 0.030 |
Why?
|
| Colonic Polyps | 1 | 2016 | 557 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1396 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1997 | 1304 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1999 | 3464 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 1996 | 1183 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 1135 | 0.020 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 1996 | 1399 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2783 | 0.020 |
Why?
|
| Adenoma | 1 | 2016 | 2155 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1996 | 3043 | 0.010 |
Why?
|
| Hepatitis C | 1 | 1995 | 1594 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1996 | 2535 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1995 | 2330 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12069 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 2003 | 386 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2003 | 1606 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1995 | 4357 | 0.010 |
Why?
|
| Reoperation | 2 | 1999 | 4325 | 0.010 |
Why?
|
| Liver Cirrhosis | 2 | 1999 | 1959 | 0.010 |
Why?
|
| Ileum | 1 | 1999 | 558 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 1996 | 112 | 0.010 |
Why?
|
| Rectum | 1 | 1999 | 898 | 0.010 |
Why?
|
| Liver Transplantation | 2 | 1997 | 2416 | 0.010 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 1996 | 225 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2016 | 54886 | 0.010 |
Why?
|
| Adult | 6 | 2016 | 223317 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 1997 | 364 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40154 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1997 | 676 | 0.010 |
Why?
|
| Portal Vein | 1 | 1996 | 437 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1995 | 526 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1996 | 915 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1996 | 541 | 0.010 |
Why?
|
| Phospholipids | 1 | 1996 | 778 | 0.010 |
Why?
|
| Colon | 1 | 1999 | 1797 | 0.010 |
Why?
|
| Male | 6 | 2016 | 364203 | 0.010 |
Why?
|
| Middle Aged | 4 | 2016 | 223233 | 0.010 |
Why?
|
| Aged | 3 | 2016 | 171319 | 0.010 |
Why?
|
| Doxorubicin | 1 | 1995 | 2229 | 0.000 |
Why?
|
| Cell Division | 1 | 1996 | 4473 | 0.000 |
Why?
|
| Treatment Outcome | 3 | 2003 | 65295 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 12986 | 0.000 |
Why?
|
| Female | 5 | 2016 | 396660 | 0.000 |
Why?
|
| Humans | 8 | 2016 | 767040 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1995 | 2867 | 0.000 |
Why?
|
| Survival Rate | 1 | 1999 | 12823 | 0.000 |
Why?
|
| Radiography | 1 | 1995 | 6975 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12414 | 0.000 |
Why?
|
| Recurrence | 1 | 1996 | 8504 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 8535 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17608 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1996 | 12451 | 0.000 |
Why?
|
| Kidney | 1 | 1996 | 7063 | 0.000 |
Why?
|
| Liver | 1 | 1996 | 7578 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1997 | 15925 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1999 | 39317 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1999 | 59548 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1996 | 15824 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1999 | 81659 | 0.000 |
Why?
|
| Risk Factors | 1 | 1996 | 74886 | 0.000 |
Why?
|